BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36570769)

  • 21. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Kim KH; Jung YJ; Lee Y; Park BR; Oh J; Lee YN; Kim MC; Jeeva S; Kang SM
    Virology; 2020 Nov; 550():51-60. PubMed ID: 32882637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
    Deng L; Ibañez LI; Van den Bossche V; Roose K; Youssef SA; de Bruin A; Fiers W; Saelens X
    PLoS One; 2015; 10(5):e0126650. PubMed ID: 25973787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.
    Kim MC; Lee JS; Kwon YM; O E; Lee YJ; Choi JG; Wang BZ; Compans RW; Kang SM
    Antiviral Res; 2013 Sep; 99(3):328-35. PubMed ID: 23811283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody.
    Cho KJ; Schepens B; Seok JH; Kim S; Roose K; Lee JH; Gallardo R; Van Hamme E; Schymkowitz J; Rousseau F; Fiers W; Saelens X; Kim KH
    J Virol; 2015 Apr; 89(7):3700-11. PubMed ID: 25609808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses.
    Wang Q; Zhang Y; Zou P; Wang M; Fu W; She J; Song Z; Xu J; Huang J; Wu F
    Front Microbiol; 2020; 11():1961. PubMed ID: 32922379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ancient species offers contemporary therapeutics: an update on shark V
    English H; Hong J; Ho M
    Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.
    Feng J; Zhang M; Mozdzanowska K; Zharikova D; Hoff H; Wunner W; Couch RB; Gerhard W
    Virol J; 2006 Dec; 3():102. PubMed ID: 17150104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
    Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA
    J Virol; 2002 Feb; 76(3):1391-9. PubMed ID: 11773413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.
    De Vlieger D; Hoffmann K; Van Molle I; Nerinckx W; Van Hoecke L; Ballegeer M; Creytens S; Remaut H; Hengel H; Schepens B; Saelens X
    Front Immunol; 2019; 10():2920. PubMed ID: 31921179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection.
    Padilla-Quirarte HO; Badillo-Godinez O; Gutierrez-Xicotencatl L; Acevedo-Betancur Y; Luna-Andon JD; Montiel-Hernandez JL; Lopez-Guerrero DV; Esquivel-Guadarrama F
    Vaccine; 2019 May; 37(19):2624-2633. PubMed ID: 30955979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection.
    Pendzialek J; Roose K; Smet A; Schepens B; Kufer P; Raum T; Baeuerle PA; Muenz M; Saelens X; Fiers W
    Antiviral Res; 2017 May; 141():155-164. PubMed ID: 28257797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunization with an attenuated
    Hajam IA; Kirthika P; Hewawaduge C; Jawalagatti V; Park S; Senevirathne A; Lee JH
    Avian Pathol; 2020 Oct; 49(5):486-495. PubMed ID: 32483989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shark Attack: high affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation.
    Zielonka S; Weber N; Becker S; Doerner A; Christmann A; Christmann C; Uth C; Fritz J; Schäfer E; Steinmann B; Empting M; Ockelmann P; Lierz M; Kolmar H
    J Biotechnol; 2014 Dec; 191():236-45. PubMed ID: 24862193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
    Wang C; Takeuchi K; Pinto LH; Lamb RA
    J Virol; 1993 Sep; 67(9):5585-94. PubMed ID: 7688826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
    Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
    Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA vaccine targeting the ectodomain of influenza M2 protein to endolysosome pathway enhances anti-M2e protective antibody response in mice.
    Hollý J; Tomčíková K; Vozárová M; Fogelová M; Jakubcová L; Varečková E; Kostolanský F
    Acta Virol; 2021; 65(2):181-191. PubMed ID: 34130469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.
    Soboleski MR; Gabbard JD; Price GE; Misplon JA; Lo CY; Perez DR; Ye J; Tompkins SM; Epstein SL
    PLoS One; 2011; 6(7):e21937. PubMed ID: 21789196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
    Stepanova LA; Kovaleva AA; Potapchuk MV; Korotkov AV; Kupriianov VV; Blokhina EA; Kotliarov RIu; Tsybalova LM
    Vopr Virusol; 2013; 58(3):21-5. PubMed ID: 24006628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
    Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
    J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.